Markets
markets

Marvell jumps after Bloomberg reports that SoftBank explored a potential takeover of the company earlier this year

Marvell Technology is trading more than 9% higher on Thursday morning after Bloomberg reported that investment giant SoftBank flirted with the idea of potentially taking over the US chipmaker earlier this year.

Citing people familiar with the matter, Bloomberg added that SoftBank’s billionaire founder, Masayoshi Son, has been evaluating Marvell as a possible target for years, with the idea of combining the company with UK chip designer Arm Holdings, of which it owns a majority stake. Marvell specializes in taking chip design elements, like those offered by SoftBank’s Arm, and bringing them together into final blueprints that manufacturers can put into production.

Per Bloomberg, the two sides were unable to reach an agreement after the Japanese conglomerate made overtures several months ago, and they’re not currently in active negotiations.

Marvell’s stock has shed 18% so far this year, before this latest uptick, in contrast to the massive gains of many of its chipmaking peers.

Citing people familiar with the matter, Bloomberg added that SoftBank’s billionaire founder, Masayoshi Son, has been evaluating Marvell as a possible target for years, with the idea of combining the company with UK chip designer Arm Holdings, of which it owns a majority stake. Marvell specializes in taking chip design elements, like those offered by SoftBank’s Arm, and bringing them together into final blueprints that manufacturers can put into production.

Per Bloomberg, the two sides were unable to reach an agreement after the Japanese conglomerate made overtures several months ago, and they’re not currently in active negotiations.

Marvell’s stock has shed 18% so far this year, before this latest uptick, in contrast to the massive gains of many of its chipmaking peers.

More Markets

See all Markets
markets

CarMax plunges on weak preliminary sales results and the sudden firing of its CEO

CarMax shares are down more than 11% in premarket trading on Thursday following the sudden termination of its CEO, Bill Nash, who’d served as chief executive for nine years.

The announcement came as CarMax posted preliminary third-quarter results, including an expected comparable-store unit sales decrease of 8% to 12%.

“CarMax is the nation’s largest used car retailer because we have built a business that customers trust,” said CarMax Board Chair Tom Folliard, who has been named the company’s interim CEO. “However, our recent results do not reflect that potential and change is needed.”

Folliard previously served as CarMax’s CEO for 10 years until Nash succeeded him.

The leadership change comes as CarMax rival Carvana closes its unit sales gap quarter by quarter. Despite selling more used vehicles, CarMax’s market cap is less than a tenth of Carvana’s.

“CarMax is the nation’s largest used car retailer because we have built a business that customers trust,” said CarMax Board Chair Tom Folliard, who has been named the company’s interim CEO. “However, our recent results do not reflect that potential and change is needed.”

Folliard previously served as CarMax’s CEO for 10 years until Nash succeeded him.

The leadership change comes as CarMax rival Carvana closes its unit sales gap quarter by quarter. Despite selling more used vehicles, CarMax’s market cap is less than a tenth of Carvana’s.

markets

Oscar Health beats on adjusted EPS by a penny, CEO says it will “return to profitability” in 2026

Oscar Health rose in premarket trading after it reported earnings results that edged ahead of Wall Street expectations by a penny.

The company reported a loss per share of $0.53, compared to the $0.54 loss per share analysts polled by FactSet were penciling in. Oscar reported $2.92 billion in revenue, compared to $3.07 billion analysts expected.

Oscar CEO Mark Bertolini said in a statement that the company is “confident in our ability to expand margins and return to profitability in 2026.”

It also reported a medical loss ratio, a key metric that measures how much revenue from premiums is spent on providing care, of 88.5%, a slightly better result than the 88.8% the Street was expecting. Health insurance companies — particularly those that provide government-sponsored plans, like Oscar — have had a tumultuous year amid soaring medical costs.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.